Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study

Purpose: There is uncertainty regarding the appropriate dose of Cannabidiol (CBD) for childhood epilepsy. We present the preliminary data of seven participants from the Cannabidiol in Children with Refractory Epileptic Encephalopathy (CARE-E) study.Methods: The study is an open-label, prospective, d...

全面介紹

書目詳細資料
Main Authors: Richard J. Huntsman, Richard Tang-Wai, Jane Alcorn, Stephanie Vuong, Bryan Acton, Scott Corley, Robert Laprairie, Andrew W. Lyon, Simona Meier, Darrell D. Mousseau, Doris Newmeyer, Erin Prosser-Loose, Blair Seifert, Jose Tellez-Zenteno, Linda Huh, Edward Leung, Philippe Major
格式: Article
語言:English
出版: Frontiers Media S.A. 2019-07-01
叢編:Frontiers in Neurology
主題:
cannabidiol
Δ9-tetrahydrocannabinol
cannabis
epileptic encephalopathy
cannabinoid plasma levels
在線閱讀:https://www.frontiersin.org/article/10.3389/fneur.2019.00716/full

因特網

https://www.frontiersin.org/article/10.3389/fneur.2019.00716/full

相似書籍